pd 98059 has been researched along with Angiosarcoma in 1 studies
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one: inhibits MAP kinase kinase (MEK) activity, p42 MAPK and p44 MAPK; structure in first source
2-(2-amino-3-methoxyphenyl)chromen-4-one : A member of the class of monomethoxyflavones that is 3'-methoxyflavone bearing an additional amino substituent at position 2'.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| LaMontagne, KR | 1 |
| Moses, MA | 1 |
| Wiederschain, D | 1 |
| Mahajan, S | 1 |
| Holden, J | 1 |
| Ghazizadeh, H | 1 |
| Frank, DA | 1 |
| Arbiser, JL | 1 |
1 other study available for pd 98059 and Angiosarcoma
| Article | Year |
|---|---|
Inhibition of MAP kinase kinase causes morphological reversion and dissociation between soft agar growth and in vivo tumorigenesis in angiosarcoma cells.
Topics: Agar; Animals; Cell Cycle; Cell Division; Chromones; Dose-Response Relationship, Drug; Enzyme Inhibi | 2000 |